Image

U.S. Meniere’s Disease Drug Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

U.S. Meniere’s Disease Drug Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • Country Level
  • 350 Pages
  • No of Tables: 12
  • No of Figures: 39

U.S. Meniere’s Disease Drug Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 126.50 USD Million
Diagram Market Size (Forecast Year) USD 178.50 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

U.S. Meniere’s Disease Drug Market, By Type (Classic, Bilateral, Vestibular), Treatment (Drug, Surgical, Suplemental Therapies & Procedure), Drug Type (Generics, Branded), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) – Industry Trends and Forecast to 2030.

 U.S. Meniere’s Disease Drug Market Analysis and Size

Rising number of meniere’s disease drugs as compared to the last few years will incease the market growth. As per the National Institute on Deafness and Other Communication Disorders, about 615,000 people in the U.S. have Meniere's disease. Rigorous regulation protocols by regulatory authorities is hindering the meniere’s disease drugs market that further creates new opportunities for the market.

Data Bridge Market Research analyses a growth rate in the meniere’s disease drug market in the forecast period 2023-2030. The expected CAGR of meniere’s disease drug market is tend to be around 4.4% in the mentioned forecast period. The market value is USD 126.5 million in 2022, and it would grow upto USD 178.5 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

U.S. Meniere’s Disease Drug Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Classic, Bilateral, Vestibular), Treatment (Drug, Surgical, Suplemental Therapies & Procedure), Drug Type (Generics, Branded), Route of Administration (Oral, Parenteral),End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)

Market Players Covered

Agouron Pharmaceuticals, LLC (U.S.), AHP Holdings B.V. (Netherlands), Alacer Corp. (U.S.), Alpharma Pharmaceuticals LLC (U.S.), Bioren, LLC (U.S.) and G. D. Searle & Co. Limited (U.K.) Hikma Pharmaceuticals PLC (U.K.), Mylan N.V.(U.S.), Pfizer Inc.(U.S.), Fresenius Kabi AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland)

Market Opportunities

  • Growing Demand of Vestibular Nerve Segment
  • Increasing Advancements in Medicinal & Pharmacy Therapeutics

Market Definition

Meniere’s disease is a type of middle ear disorder that leads to ear ringing (tinnitus), vertigo, ear pain and hearing problems. People suffering from Meniere’s disease generally experience these symptoms during sudden episodes, that specifically last around two to three hours. The patient experiences recurrent episodes of vertigo. The vertigo tends to occur less commonly during the later stages, whereas the tinnitus and hearing loss often become worse and the patient may suffer from permanent balance and hearing issues.

U.S. Meniere’s Disease Drug Market Dynamics

Drivers

  • Rising Prevalence of Meniere’s Disease

As per the National Institute on Deafness and Other Communication Disorders, around 615,000 people in the U.S. suffer from Meniere's disease. In 2019, Hearing Health Foundation estimated that there are around 600,000-750,000 meniere’s disease cases combined with 45,000 to 60,000 new cases diagnosis in the U.S. Majority of the meniere’s disease cases are unilateral, but then as per the records, 15% to 40% of total patients are affected in both ears. Thus, this boost the growth of the treatment market.

  • Increasing Demand of Off label Drugs

Off label drugs lead the largest market share primarily because of the absence of novel therapeutics in the market. Though, some of the companies are conducting huge studies to develop a drug dedicated for the treatment of Meniere disease, the increasing absence of the cause of disease development, makes it a tedious process. Tranquillizers hold the major market share since they are prescribed for vertigo and vomiting, which are the disease's primary symptoms. Thus, this boost the market growth.

Opportunities

  • Growing Demand of Vestibular Nerve Segment

The vestibular nerve section surgical procedure opens the internal auditory canal and the procedure is specifically carried out through either a retrosigmoid or a middle fossa approach. The middle fossa approach for vestibular nerve section is technically more difficult. The benefit of the middle fossa approach is that it achieves a relatively more complete ablation of vestibular function compared to the retrosigmoid approach because of the vestibular fibers. The vestibular nerve section has the biggest advantage of a high rate of vertigo control around 95-98% with an increased hearing preservation rate in the operated ear. Thus, this boost the market growth.

  • Increasing Advancements in Medicinal & Pharmacy Therapeutics

Huge advancements in medicinal and pharmacy therapeutics related with Meniere’s diseases are pushing the Meniere’s disease treatment market. Increasing use of injectable and surgical procedures is being used regularly for the treatment of patients suffering from Meniere’s diseases. Thus, these factors are anticipated to fuel the Meniere’s disease treatment market during the forecast period 2023-2030. Thus, this leads to the growth of the market.

Restraints/Challenges

  • Side-Effects of Diagnostics and Treatment Methods of Meniere’s Disease

There are various side-effects that are associated with the disease such as dizziness, nausea or headache. Furthermore, diagnostic procedures such as vestibular evoked myogenic potential sound stimulation can lead to noise-induced hearing loss in many cases with high sensitivity to noise exposure or by surpassing individual cochlear safety thresholds. Thus, these factors restrict the market growth.

This meniere’s disease drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the meniere’s disease drug market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

U.S. Meniere’s Disease Drug Market Scope

The meniere’s disease drug market is segmented on the basis of type, treatment, drug type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Classic
  • Bilateral
  • Vestibular

Treatment

  • Drug
  • Short-term medications
  • Long-term medications
  • Injectable medications
  • Surgical
  • Endolymphatic sac
  • Vestibular nerve section
  • Labyrinthectomy
  • Suplemental Therapies & Procedure
  • Vestibular rehabilitation
  • Hearing aid
  • Meniett pulse generator

Drug Type

  • Generic
  • Branded

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

Distribution Channel

  • Direct Tender
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Competitive Landscape and U.S. Meniere’s Disease Drug Market Share Analysis

The meniere’s disease drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, U.S. presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to meniere’s disease drug market.

Key players operating in the meniere’s disease drug market include:

  • Agouron Pharmaceuticals, LLC (U.S.)
  • AHP Holdings B.V. (Netherlands)
  • Alacer Corp. (U.S.)
  • Alpharma Pharmaceuticals LLC (U.S.)
  • Bioren, LLC (U.S.)
  • G. D. Searle & Co. Limited (U.K.)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Mylan N.V.(U.S.)
  • Pfizer Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The U.S. Meniere’s Disease Drug Market is projected to grow at a CAGR of 4.4% during the forecast period by 2030.
The future market value of the U.S. Meniere’s Disease Drug Market is expected to reach USD 178.5 million by 2030.
The major players in the U.S. Meniere’s Disease Drug Market are Agouron Pharmaceuticals, LLC (U.S.), AHP Holdings B.V. (Netherlands), Alacer Corp. (U.S.), Alpharma Pharmaceuticals LLC (U.S.), Bioren, LLC (U.S.) and G. D. Searle & Co. Limited (U.K.) etc.
The U.S. Meniere’s Disease Drug Market is segmented on the basis of deployment type, treatment, drug type, route of administration, distribution channel and end-user.
Free Sample Report

CHOOSE LICENCE TYPE

  • 3500.00
  • 2500.00
  • 1800.00
  • 4500.00
  • 5400.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials